A genetic association study of colon cancer by Densalat Ventayol, Júlia
  
Title: A genetic association study of colon cancer 
 
Author: Júlia Densalat Ventayol 
 
Advisor: Jan Graffelman 
 
Department: Department of Statistics and Operations                 
Research 
 
Academic year: 2013/2014 
Degree in Mathematics  

Universitat Polite`cnica de Catalunya
Facultat de Matema`tiques i Estad´ıstica
Bachelor’s degree thesis
A genetic association study of colon
cancer
Ju´lia Densalat Ventayol
Advisor: Jan Graffelman
Statistics and Operations Research

To my family, who always had faith in me.

Abstract
Keywords: Statistics, genetics, colon cancer, single nucleotide polymorphism (SNP).
The project of this bachelor degree concerns the statistical analysis of a genetic database
provided by Professor Victor Moreno, epidemiologist of the Hospital de Bellvitge in Barcelona.
The goal is to investigate associations between a particular area of the genome and colon cancer.
To achieve the objective, some basic statistical genetic models such as the codominant test, the
exact test, the allele test and the Cochran-Armitage test will used to analize the data. These tests
reveal a few clusters of genetic markers that appear to be associated with colon cancer.
All statistical analysis, computations and graphics are made with the statistical enviroment R.
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Introduction
The project of this bachelor degree concerns the statistical analysis of a genetic database provided
by Professor Victor Moreno, epidemiologist of the Hospital de Bellvitge in Barcelona.
The database contains genetic information for both healthy people and for people suffering from
colon cancer.
We present a genetic association analysis that will enable us to investigate associations between
genetic markers and a disease trait, in this case, colon cancer.
Genetic association studies are performed to determine whether a genetic variant is associated with
a disease or trait: if association is present, a particular allele or genotype of a polymorphism or
polymorphisms will be seen more often than expected by chance in an individual carrying the trait.
There exist two types of genetic association studies: Family-based association studies and Population-
based association studies.
Family-based association studies
Family based association studies aim to avoid the potential confounding effects of population
stratification by using the parents or using unaffected siblings as controls for the case, which is
their affected offspring/ siblings. If an allele increases the risk of having a disease then that allele
is expected to be transmitted from parent to offspring more often in populations with the disease.
Population-based association studies
Population based association studies work with samples of individuals without family relation-
ship that are therefore considered to be independent individuals. Statistical techniques used for
population-based association studies, like for instance logistic regression, typically assume inde-
pendent observations. A typical design for population-based studies is a case-control design, with
a random sample of cases (individuals affected with the disease) and a random sample of controls.
We can also describe an association study by saying whether it is a Genome wide association study
or a Candidate region study.
2 Introduction
Genome-wide association studies (GWAS)
A genome-wide association study is an examination of many common genetic variants in different
individuals to see if any variant is associated with a trait. It scans the entire genome for common
genetic variation.
Candidate region studies
The candidate gene approach to conducting genetic association studies focuses on associations be-
tween genetic variation within pre-specified genes of interest and phenotypes or disease states.
The genetic association study that we present is a Population-based association study and a Can-
didate region study focused on chromosome 6. The chromosome 6 has been chosen because epi-
demiologists suspect that a region of this chromosome is likely to present associations between
colon cancer and the markers located on it.
A case-control design is used to do the study, in which a series of cases affected with the disease of
interest (colon cancer) are collected together with a series of control individuals.
1
Statistical and molecular
genetics
In this chapter we present some basic genetic terminology that is necessary to understand the rest
of this project.
Statistical Genetics deals with the analysis of genetic data and inherited traits. Genetic data refers
to the biological material that is inherited during reproduction via egg and sperm cells.
The Human genome refers to all of the basic biological material that is transmitted from parents
to offspring.
The heritable material is stored in chromosomes in the nucleus of every cell. Each chromosome is
composed of long strands of DeoxyriboNucleic Acid (DNA). The DNA determines how proteins are
manufactured in the body and is the basic biological material of inheritance. The human genome
consists of 23 pairs of chromosomes.
Genes are largely contiguous stretches of DNA.
Polymorphic means the data at a particular location in a chromosome can have more than one
possible variant. A polymorphism is a polymorphic genetic locus.
The different variants at a locus are called alleles. When there are only two variants, we refer to
them as ′A′ and ′a′. An individual with two copies of A (one on each of the two chromosomes) is
called homozygous AA. An individual with one A and one a is called heterozygous or Aa. Finally
an individual with two copies of a is homozygous aa. The genotype of an individual refers to the
pair of alleles at a location.
Recall that each person has two copies of each autosomal chromosome, so at any specific locus, each
person has two alleles, one inherited from each parent. The Genotype frequency in a population
is the number of individuals with a given genotype divided by the total number of individuals in
population, so it is the proportion of a given genotype in a population.
The Allele frequency in a population is defined as the proportion of chromosomes carrying that
allele, regardless of the pairing within individuals. Suppose that we have a sample of size n from
a population with a proportion, p, of A alleles. Then to estimate p, we simply count the number
of chromosomes carrying the A allele and divide by 2n, the number of chromosomes.
The Minor allele frequency (MAF) refers to the frequency at which the least common allele occurs
in a population.
A trait, also known as the phenotype, is used to mean individual characteristics that have a heritable
basis.
A genetic marker is a gene or DNA sequence with a known location on a chromosome that allows
us to distinguish genetic differences in individuals. Having marker data for samples of families has
enabled to create a variety of methods to find the chromosomal location of a disease-causing gene.
A disease susceptibility locus indicates a specific genetic locus, which has a variant associated with
a disease.
The simplest type of genetic marker is a single nucleotide polymorphism (SNP ). A SNP is the
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most common type of genetic variation among people. It is a variation at a single position in
a DNA sequence among individuals. Recall that the DNA sequence is formed from a chain of
four nucleotide bases: A, C, G, and T. If more than 1% of a population does not carry the same
nucleotide at a specific position in the DNA sequence, then this variation can be classified as a
SNP .
Although a particular SNP may not cause a disorder, some SNPs are associated with certain
diseases. These associations allow scientists to look for SNPs in order to evaluate an individual’s
genetic predisposition to develop a disease. In addition, if certain SNPs are known to be associated
with a trait, then scientists may examine stretches of DNA near these SNPs in an attempt to
identify the gene or genes responsible for the trait.
Over 10 million SNPs have been identified in the human genome. SNPs occur at a rate of about
1 in 300 nucleotides.
From a statistical point of view a SNP is a categorical variable. Theoretically, this categorical
variable can have 10 possible categories if the SNP has all four possible alleles (A,C,G,T). In
practice almost all SNPs are bi-allelic, and therefore only 3 genotypes will exist. In this case, a
SNP is a categorical variable with 3 classes.
A genetic model describes the relationship between an individual’s genotype and their phenotype.
2
Describing the data
In this chapter we present the data set being studied and give a descriptive analysis of the data.
2.1 Structure of the database
The dataset we are using to do this study contains two objects, one called “calls” and the other
called “annot”.
Object “calls” is a table with 1685 rows and 146 columns. Each row represents a bi-allelic poly-
morphism and each column represents an individual. Our study is based, then, on information
about 146 individuals.
There’s also an index indicating whether an individual is sick of colon cancer or not. The index
has value M if the individual has the disease and N if not. Table “calls” contains numbers from
1 to 3. Number 1 indicates homozygous AA, number 2 indicates heterozygous Aa and number 3
indicates homozygous aa. Further, we can occasionally find ’NA’ which means the value is missing.
This table then, gives us the genotypes of each individual for each marker.
To start with, we will transpose the table “calls” in order to have the individuals represented in
rows (we will use the same name for this table).
Thus, callsij = 1 means the individual i is homozygous AA for the marker j.
The genotypes of the first 10 individuals for the 10 first markers are given below.
1 2 3 4 5 6 7 8 9 10
1 N 1 1 3 3 1 3 1 1 1 1
2 N 1 2 2 1 3 1 2 2 3 1
3 N 3 1 3 NA 1 3 3 3 1 1
4 N 1 2 2 2 2 2 1 1 3 1
5 M 2 1 3 2 2 2 3 3 2 1
6 N 1 2 2 2 2 2 1 1 3 1
7 N 1 1 3 2 2 2 2 2 1 1
8 N 3 1 3 3 1 3 3 3 1 1
9 N 2 1 3 3 1 3 2 2 1 1
10 M 2 1 3 2 2 2 3 3 1 1
Table 2.1: Genotypes of the first 10 individuals for the first 10 markers
The object “annot” contains information of the markers. It is a table of 1685 rows. Each row
represents a marker and for each one of them we have the two different variants (alleles). We also
have the minor allele frequency and also the position on chromosome 6 of each marker measured
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in base pairs.
Let’s see all this information for the first 10 markers.
Allele.A Allele.a Minor.Allele.Caucassian MAF position
1 G T T 0.28 1
2 A T T 0.26 338
3 G T G 0.26 4815
4 A C A 0.38 4864
5 A G G 0.40 4876
6 A G A 0.38 4939
7 C T T 0.48 17064
8 C T T 0.48 17279
9 C T T 0.42 19412
10 C T T 0.04 23888
Table 2.2: Information of the first 10 markers from objet annot
For example, the first row indicates that the first bi-allelic polymorphism marker on chromosome 6
is the one that occupies the first position on the chromosome. It also indicates that the two variants
that this marker can take are G and T and the Minor Allele Frequency (allele T ) is 0.28833.
We have the genotypes of 1685 markers of 146 individuals. To start with, let’s find out how many
of them are controls (don’t have the disease) and how many are cases (have colon cancer).
# individuals
Cases 47
Controls 99
Table 2.3: Composition of the database
As we see in the table, we have 47 cases and 99 controls.
2.2 Missing data
What is next is to investigate whether the dataset we are working with is good enough. That
means it doesn’t have too many missing values.
We may want to know, for each individual, the % of missing genotypes. We do this in order to
decide if all the individuals are useful. For example, if one individual had missing genotypes for
more than the 50% of the markers, then we would remove this individual from the study.
In this case, we will consider a 10% as a limit.
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Figure 2.1: Plot of the percentage of missing values for each individual of the database
Figure 2.1 shows that almost all individuals have less than 10% missing values, and that there is
no need to remove individuals from the database.
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The next step is to calculate for each marker, the % of individuals that don’t have a genotype of
the marker. We do this in order to detect if there is a marker that we can’t use to do the study.
For example, if for the 50% of the individuals, we don’t have the genotype of a particular marker,
then we do not have enough information to analyze this marker and so we will remove it from the
database.
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Figure 2.2: Plot of the percentage of missing values for each SNP of the database
Figure 2.2 shows that there are a few markers with a lot of missing values. Markers with more
than 50% missing values were considered unreliable and were removed from the database. Initially
we had 1685 markers but after this removal we got 1675.
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2.3 Distribution of Minor Allele Frequency
Although, object “annot” contains the Minor Allele Frequency (MAF ) for each marker, we are
going to calculate it from the marker data that we have and we are going to estimate its probability
function by making an histogram.
Calculation of Estimated Allele Frequencies from a Sample of n Subjects
Given the genotype counts for the sample:
nAA = number out of n with genotype AA
nAa = number out of n with genotype Aa
naa = number out of n with genotype aa
where nAA + nAa + naa = n. The sample proportion of A alleles,
pˆ =
(2nAA + nAa)
2n
(2.1)
estimates the A allele frequency. With a two allele system, the a allele frequency is qˆ = 1− pˆ.
Thus, MAF = min(pˆ, qˆ).
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After calculating the MAF for each SNP of the database we make a histogram with the results
that have been obtained.
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Figure 2.3: Histogram of the Minor Allele Frequency
Figure 2.3 shows that the Minor Allele Frequency is not uniformly distributed, but that markers
with a low MAF (in the range 0.0 − 0.1) are relatively more common. Marker with a 0.1 or low
MAF are generally considered less informative because they have a lower variance.
How many monomorphic SNPs do we have?
A monomorphic SNP is a SNP for which a single form or allele can be identified in the population
of interest. Equivalently, a SNP is monomorphic if MAF = 0.00.
As it is shown in figure 2.3, there are a lot of markers with a MAF in the range 0.00− 0.05 and
so there can be markers with MAF = 0.00. We are going to report the number of monomorphic
markers and eliminate them.
Doing the appropriate calculations we find out that 109 markers of our data marker are monomor-
phic. That means a single genotype is found for these markers in our population, and so these
markers have zero variance and are not informative for our study. After the removal of these
markers we now dispose of 1566 markers.
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We now repeat the histogram of the MAF. This time we will not take into account the monomorphic
SNPs.
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Figure 2.4: Histogram of the Minor Allele Frequency of the non-monomorphic SNPs
Comparing 2.4 with 2.3 we see that before removing the monomorphic SNPs we had nearly 400
markers in the range 0.0 - 0.05, but now we have less than 300. In any case, the MAF is not
uniformly distributed.
2.4 Hardy-Weinberg equilibrium
In 1908, Godfrey Hardy 1 and Wilhelm Weinberg 2 independently derived a formula relating allele
frequencies in parents to genotype frequencies in offspring.
Hardy-Weinberg equilibrium principle (HWE)
Let p be the frequency of the A allele and q be the frequency of the a allele, such that p+ q = 1.
A population is in Hardy-Weinberg Equilibrium if the genotype frequencies in the offspring are
given by:
1Godfrey Harold Hardy (7 February 1877 - 1 December 1947 was an English mathematician, known for his
achievements in number theory and mathematical analysis
2Dr. Wilhelm Weinberg (Stuttgart, December 25, 1862 - Tu¨bingen, November 27, 1937) was a German physician
credited as the first to explain the effect of ascertainment bias on observations in genetics
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fAA = P (AA) = p
2
fAa = P (Aa) = 2pq
faa = P (aa) = q
2
If this happens, then the frequency of the A allele among the offspring is also p and that means that
under Equilibrium, allele frequencies will not change from generation to generation. Consequently,
the genotype frequencies will also remain the same over the generations.
An alternative formulation of HWE is obtained by squaring the heterozygote frequency giving:
f2Aa = 4p
2q2 = 4fAAfaa
which gives an exact mathematical relationship between the 3 genotype frequencies.
There are some assumptions required for this formula to hold:
The organism we are studying is diploid
There is sexual reproduction
Mutation can be ignored
Migration is negligible
Natural selection does not affect the trait under study
Random mating
Despite none of these assumptions is likely to hold exactly in any populations, the principle pro-
vides a good approximation for population genotype frequencies.
Genetic markers are, in general, expected to follow HWE. If they do not follow the equilibrium is
probably because of genotyping error. Genotyping error consists of confounding homozygotes with
heterozygotes. E.g. a heterozygote AB is classified in the laboratory as AA or the reverse.
For this reason, markers need to be checked for HWE as part of a quality control procedure.
Do our markers follow the HWE?
To do this check for our markers, we are going to use an R package called HardyWeinberg [1]. It
constructs ternary plots for genotypic compositions for bi-allelic marker data.
The most important routine of the package is the HWTernaryP lot function that draws a ternary
plot for three-way genotypic compositions (AA,Aa, aa), and represents the acceptance region for
different tests for HWE in the plot.
HWE can be inferred from the position of the marker in the ternary plot (see Figure 2.5 ). A
marker that is in perfect equilibrium is on the parabola inside the ternary diagram. Markers that
are, statistically speaking, in equilibrium, will be close to the parabola, inside the banana-shaped
acceptance region in the plot (Graffelman & Morales) [2].
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Figure 2.5: Ternary plot showing the parabola and the acceptance region corresponding to a Chi-square
test
Different statistical tests for HWE can be done graphically with this routine: the ordinary chi-
square test, the chi-square test with continuity correction and Haldane’s exact test.
How do we obtain expressions for the curves that bound the acceptance region for HWE, for
example, for the χ2 test?
Let fAA, fAa and faa be the genotype frequencies, and eAA, eAa, eaa the expected frequencies un-
der HWE. Let n be the sample size and D the deviation from independence for the heterozygote
given by 12 (fAa − eAa). Then the χ2 statistic for testing HWE is:
X2 =
D2
p2q2n
(2.2)
Where X2 ∼ χ21
By substituting D = 12 (fAa−eAa), we can rewrite Eq.(2) and express the relative sample frequency
of heterozygotes rAa in terms of the allele frequency p to obtain the parabolas:
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rAa = 2pq ± 2pq
√
X2
n
(2.3)
Sample heterozygote frequencies lie on the upper parabola if D > 0 which means heterozygote
excess and on the lower parabola if D < 0 which means heterozygote dearth. Exact HWE is
achieved when X2 = 0.
For D > 0, we reject HWE when X2 > χ21(α)
3 or equivalently when rAa exceeds 2pq+2pq
√
χ21(α)
n .
For D < 0, we reject HWE when X2 < χ21(α) or equivalently when rAa is below 2pq−2pq
√
χ21(α)
n .
The acceptance region for HWE can thus be given in terms of the relative heterozygote frequency
by:
(2pq − 2pq
√
χ21(α)
n
≤ rAa ≤ 2pq + 2pq
√
χ21(α)
n
) (2.4)
3100(1-α) percentile of a χ21 distribution
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We now show the ternary plot of 1566 SNPs for the population we are studying (146 individuals).
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Figure 2.6: Ternary plot of the 1566 markers with the acceptance region corresponding to a Chi-square
test
Figure 2.6 shows the ternary plot where markers in red are significant and markers in green are
non-significant. They are colored automatically according to the result of a chi-square significance
test.
In this case we find 138 significant markers that correspond to 8.81% of the total.
Note that HWE is refused in general, more frequently, because of heterozygote dearth rather than
heterozygote excess.
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HWE for cases and controls
Some investigators think that HWE is more likely to hold for controls than for cases. Cases may
be subject to differential survival because of the disease and this could have distorted the HW
proportions. For this reason, we are going to make an analysis of HWE stratified for cases and
controls.
HWE for cases
We want to check if HWE holds in cases population (47 individuals).
AA
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aa
Figure 2.7: Ternary plot of the 1566 markers in Cases with the acceptance region corresponding to a
Chi-square test
We find 92 significant markers, corresponding to 5.87% of the total.
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HWE for controls
We check now if HWE holds in controls populations (99 individuals).
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Figure 2.8: Ternary plot of the 1566 markers in Controls with the acceptance region corresponding to
a Chi-square test
We find 113 significant markers, corresponding to 7.21% of the total.
We have not found evidence for more disequilibrium in cases but in controls. This result is rea-
sonable because the sample size of controls doubles the sample size of cases and so there is more
power to detect effects in controls.
sample size significant markers % significant
Cases 47 92 5.87%
Controls 99 113 7.21%
Total 146 138 8.81%
Table 2.4: Results of testing for HWE
18 Chapter 2. Describing the data
3
Genetic Association
Analysis
As we mentioned, our goal is to investigate associations between markers and a trait (in this case:
colon cancer’s disease). The markers we are studying (1566) are bi-allelic polymorphisms. For each
marker, we can test for association with the disease using different models.
3.1 General Theory
In this section we are going to present different statistical tests for marker-disease association. We
subsequently describe four different statistical tests in the subsections below: the codominant test,
Fisher’s exact test, the alleles test and the Cochran Armitage trend test.
3.1.1 Codominant Test
We may consider the variable Yi that takes value 1 if the individual i has the disease and value 0
if the individual does not have the disease. Further, as our markers are bi-allelic polymorphisms
we can only have three different genotypes for each marker (AA,Aa, aa).
Individuals are organized into genotypic contingency tables according to their marker and disease
status. Thus, we classify cases and controls according to their genotypes.
AA Aa aa Total
Cases r0 r1 r2 r
Controls s0 s1 s2 s
Total n0 n1 n2 n
Table 3.1: Genotypic contingency table
We want to test the null hypothesis of no effect of a marker on the trait.
We construct then a test of independence between the disease and genotype where the null and
alternative hypothesis are the following:
H0 : P (Y = 1 | AA) = P (Y = 1 | Aa) = P (Y = 1 | aa)
H1 : At least one pair of probabilities is different
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The test statistic is:
X2 =
∑
i,j
(oij − eij)2
eij
(3.1)
where oij is the observed count and eij is the expected count cell (row total*column total / N).
Under H0, we have X
2 ∼ χ22. So, X2 follows a chi- square distribution with two degrees of freedom
(df) where df is given by (nc − 1) ∗ (nr − 1), with nc = number of columns and nr = number of
rows of the contingency table.
3.1.2 Fisher’s Exact Test
Fisher’s exact test is a statistical significance test used in the analysis of contingency tables. It is
named after its inventor, R. A. Fisher 1.
His motivating example was as follows. A British woman claimed to be able to distinguish whether
milk or tea was added to the cup first and in order to test this claim she was given eight cups of
tea. In four of them, tea was added first and in the other four, milk was added first. The cups
were presented to her in a randomized order and she was told that there were four cups of each type.
For the contingency table, Fisher noted that under the null hypothesis of independence, if you as-
sume fixed marginal frequencies for both the row and column marginals, then the hypergeometric
distribution characterizes the distribution of the cell counts. This fact enables us to calculate an
exact p-value rather than rely on an approximation that becomes exact in the limit as the sample
size grows to infinity.
The p-value of the test is obtained by summing the probabilities of all possible tables that have
the same margins as the observed table, but deviate as much or more from independence.
Ideally, we would use exact p-values all of the time. In practice, however, it is not possible because
the algorithms in Exact Tests might break down as the size of the data set increases, as they require
more computation time.
3.1.3 Allele test
This test aims to identify significant differences in allelic proportions between case and controls
items. One supposes that alleles are binomially and independently sampled from cases and con-
trols with probabilities pDA and pHA corresponding to the proportions of the A allele in the two
sub-groups.
A a Total
Cases DA(= 2r0 + r1) Da(= 2r2 + r1) 2r
Controls HA(= 2s0 + s1) Ha(= 2s2 + s1) 2s
Total NA(= 2n0 + n1) Na(= 2n2 + n1) 2N
Table 3.2: Allelic contingency table
1Sir Ronald Aylmer Fisher(17 February 1890 - 29 July 1962) was an English statistician, evolutionary biologist,
geneticist, and eugenicist
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We want to test:
H0 : pDA = pHA
H1 : pDA 6= pHA
According to the null hypothesis, alleles are sampled from the same general population and allele
frequency are the same for cases and controls.
Generally, we consider the following statistic
ZA =
p̂DA − p̂HA√
Np̂(1− p̂) (3.2)
where p̂DA =
DA
2r , p̂HA =
HA
2s and p̂ =
NA
2N
Under H0, the p value can be calculated by considering that ZA follows a Gaussian N(0, 1) distri-
bution. When the sample size is small, a Fisher exact test leads to an exact computation of the
p-value as we mentioned before.
We can also use the equivalent Pearson 2 statistic:
X2 = (ZA)
2 (3.3)
Using this statistic, the p value is calculated by considering that X2 ∼ χ21.
3.1.4 Cochran-Armitage test
In case-control studies evaluating association between a candidate allele and a disease, allele and
trend statistics are asymptotically equivalent when HWE holds. However, Sasieni [3] demonstrates
that when HWE is not satisfied, the allele test is not valid and the Cochran-Armitage (CA) trend
test can be used.
The trend test is based on the linear regression model.
If we define X as the number of A alleles and Y codes for cases and controls, i.e., Y = 1 for cases
and Y = 0 for controls, then
P (Y = 1 | X) = β0 + β1X + ε
We can use ordinary linear regression to estimate β1 and test:
H0 : β1 = 0
H1 : β1 6= 0
An alternative method is to treat X as a scaled (0,1,2) random variable giving the number of A
alleles and compare the means of X in the two groups. By definition, sample means of X in the
two groups and overall are
X¯cases =
2r0 + r1
r
= 2pˆcases (3.4)
2Karl Pearson (27 March 1857 - 27 April 1936) was an influential English mathematician and biometrician
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X¯controls =
2s0 + s1
s
= 2pˆcontrols (3.5)
and
X¯ = 2pˆ. (3.6)
Thus, testing pcases = pcontrols is equivalent to testing that the means of X are equal in the two
groups:
H0 :E(X | case) = E(X | control)
H1 :E(X | case) 6= E(X | control)
It can be shown that, under H0,
var(X¯cases − X¯controls) = var(X)
(
1
r
+
1
s
)
(3.7)
Further, var(X) can be estimated from the sample variance of the data by
V̂ ar(X) =
4n0 + n1 − nX¯2
rs
(3.8)
As a result, we have that the test statistic for the trend test is:
Z =
X¯cases − X¯controls√
4n0+n1−nX¯2
rs
(3.9)
Under H0, Z ∼ N(0, 1). Alternatively, Z2 ∼ χ21.
3.2 Example of each test for the first marker
In order to show clearly how the tests explained above work, we are going to do all the tests for
the first SNP of the database.
We choose for all of them α = 0.05 as the significance level.
Statistical significance is the low probability that an observed effect would have occurred due to
chance. In any experiment or observation that involves drawing a sample from a population, there
is always the possibility that an observed effect would have occurred as a result of just chance (or
sampling error) alone. But if the probability of such chance effects is less than a pre-determined
threshold (in this case 0.05), then an investigator can conclude that the observed effect actually
reflects the characteristics of the population rather than just sampling error.
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3.2.1 Codominant Test for the first SNP
We are going to do an example of the codominant test for the first marker.
First, we may be interested in knowing how many homozygous AA, heterozygous Aa and homozy-
gous aa do we have for the first marker.
# individuals
AA 72
Aa 60
aa 13
Table 3.3: Genotype counts for the first SNP
Next, we need to construct the genotypic contingency table for this marker. It is important to
realize that there is one individual that does not have any genotype described for this marker but
we already managed with missing values before.
AA Aa aa
cases 27 16 3
controls 45 44 10
Table 3.4: Genotypic contingency table for the first SNP
The chisq.test function in R performs chi-squared contingency table tests and gives us the p-value,
χ2 statistic and the expected counts under the null hypothesis.
X-squared df p-value
2.2663 2 0.322
Table 3.5: Results of the codominant test for the first SNP
As the p-value > 0.05 (equivalently, the X-squared statistic < 5.99), we can’t reject the null hy-
pothesis of no effect of this marker to the disease.
A warning message is shown when performing this function in this case:
Warning: Chi-squared approximation may be incorrect.
This is because one of the expected counts is below 5 and therefore the chi-square approximation
may not be right.
In these cases a good option would be to perform the exact test which will be done for the first
SNP in the next subsection.
3.2.2 Fisher’s exact test for the first SNP
To perform the Fisher’s exact test we also need the genotypic contingency table 3.4 of the first
marker.
The fisher.test function in R performs Fisher’s exact test for testing the null of independence of
rows and columns in a contingency table with fixed marginals.
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p-value
0.3463
Table 3.6: P-value for the exact test for the first SNP
As the p-value > 0.05, we can’t reject the null hypothesis of no effect of this marker to the disease.
Note that the χ2 test and the exact test almost have the same p-value and thus lead to the same
conclusion.
3.2.3 Allele test for the first SNP
What we need first, is to construct the allelic contingency table for the first marker.
A a
Cases 70 22
Controls 134 64
Table 3.7: Allelic contingency table for the first SNP
As we mentioned while explaining the allele test theory, we can use again the Pearson statistic X2
that follows a chi-square distribution with one degree of freedom χ21, which can be calculated again
with the chisq.test function.
X-squared df p-value
2.1298 1 0.1445
Table 3.8: Results of the allele test for the first SNP
Again, as the p-value > 0.05, we can’t reject the null hypothesis of no effect of this marker to the
disease.
3.2.4 Cochran-Armitage trend test for the first SNP
In this subsection we are going to perform the Cochran-Armitage trend test for the first SNP. In
this case we have not found any function in R that gives us the p-value or the statistic for this test.
Thus, we have created a function that calculates the statistic for the trend test. Once we have the
statistic we just have to compare it with the critical value (N(0, 1)(α)), for α = 0.05
statistic
1.453423
Table 3.9: Statistic of the trend test for the first SNP
As the critical value (N(0, 1)(α)) with α = 0.05 is 1.64 and the statistic has a lower value, we can’t
reject the null hypothesis,
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3.3 Tests for all the markers
We have shown how to perform the different tests for one SNP. The next step is to do the same
but for all the markers in order to find which markers are significant in each of the tests and so
detect possible associations between these markers and the disease.
We thus describe the results of testing all the markers with the different tests we already introduced
in previous sections.
We are going to present first the Bonferroni correction.
Bonferroni correction
The correction is based on the idea that if we have n independent significance tests at the α level
and we want to guarantee that the overall significance test is still at this level, then we need to
test each individual hypothesis at a statistical significance level of 1n times what it would be if only
one hypothesis were tested. So, if it is desired that the significance level for the whole family of
tests should be α, then the Bonferroni correction would be to test each of the individual test at a
significance level of αn .
Thus, if we use the Bonferroni correction the new significance level for each individual test is:
α′ =
α
n
=
(
0.05
1566
)
(3.10)
3.3.1 Codominant test for all the SNPs
In this subsection we will do the codominant test for all the markers of our data frame.
We already create a function that performs this test for one SNP and we used it for the first
marker. Using this function we get the results of the codominant test for all the markers. It gives
us the p-value of this test for each of the markers so we can compare them with the significance level
which is 0.05 and also with the significance level defined by the Bonferroni correction, which is 0.051566 .
In order to emphasize the significant markers we apply -log() function to the p-values. Red and
green lines in the plot express the significance level without taking into account the Bonferrioni
correction and using the Bonferroni correction respectively.
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Figure 3.1: Plot of -log(p-value) of the chi-square test for each SNP of the database
Figure 3.1 shows the plot of -log(p-value) of the codominant test for each SNP of the database.
Further, the plot contains a horizontal line that allows us to see whether a marker is significant
for this test or not. If the p-value of a marker is lower than the significance level which is 0.05
(equivalently, -log(p-value) is higher than -log(0.05)) then we can reject the null hypothesis of no
effect of this marker to the disease and that means some associations could exist between this
marker and the disease.
After doing the Codominant test for all the markers, we can conclude that there are 49 signifi-
cant markers for this test that represent a 3.12% of the total. Also notice that the most significant
marker is the 1190 and that using the Bonferroni correction, we do not find any significant markers.
If the null hypothesis is true for all genetic markers then we may expect a 5% significant tests by
chance. We find nearly 3% which is below 5% so apparently data marker information is not related
to the disease.
Even so, we observe clustering of significant markers in Figure 3.1. We check for randomness of the
sequence of significant and non-significant results by using the function runs.test of tseries-package
[4].
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statistic p-value
-12.121 2.2e-16
Table 3.10: Results of the runs test for randomness
Table 3.10 gives us the statistic and the p-value of the runs test for the sequence of significant and
non-significant results for the codominant test.
As p-value (= 2.2e-16) < 0.05, we can reject the null hypothesis of randomness of the sequence.
Furthermore, it is important to know which markers are significant for the codominant test in
order to compare results between the other tests that will be performed. These markers are the
following 49.
5 7 8 12 220 242 245 429 441 480 481 579 605 688 698
752 753 754 755 756 761 762 763 772 773 774 958 976 1086 1161
1169 1177 1182 1187 1189 1190 1191 1192 1294 1298 1404 1405 1406 1408 1410
1425 1506 1507 1544
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We can also evaluate the chi-square statistic distribution with a Q-Q plot. In statistics, a Q-Q
plot is a probability plot, which is a graphical method for observing how close the probability
distribution of a sample is to a theoretical distribution by plotting their quantiles against each
other. In this case we want to see how close the distribution of the chi-square statistic is to the
Chi-square distribution.
Take in mind that some markers only have two genotypes instead of three. In this cases the chi-
square statistic follows a chi-square distribution with one degree of freedom instead of 2 (X2 ∼ χ21).
For this reason, the Q-Q plot shown in the next Figure evaluates the chi-square statistic distribution
where the chi-square statistic have been calculated for those markers that have the 3 genotypes.
Thus, we compare this distribution with the chi-square with two degrees of freedom distribution.
We have 1233 markers with 3 genotypes and 333 markers with 2 genotypes (the markers with only
one genotype were removed from the database).
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Figure 3.2: Chi-square Q-Q plot
As it is shown in Figure 3.2 the chi-square with two degrees of freedom distribution seems quite
appropriate for our data. Even so, at the upper tail of the distribution, observed values are larger
than expected for a χ22. These are, indeed, the significant tests (chi-square statistic from 5.99).
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3.3.2 Fisher’s exact test for all the SNPs
Again, we have already created a function that performs this test for one SNP so we can use it to
do the test for all of them.
We now give graphically the p-value of the Fisher’s exact test for each of the markers and we
compare it with the significance level. In order to emphasize the significant markers we apply
-log() transformation to the p-value.
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Figure 3.3: Plot of -log(p-value) of the exact test for each SNP of the database
Figure 3.3 shows the plot of -log(p-value) of the Fisher’s exact test for each of the 1566 SNPs.
Further, the plot contains an horizontal line that allows us to see whether a marker is significant
for this test or not. If the p-value of a marker is lower than the significance level (equivalently: if
-log(p-value) is higher than -log(0.05), then we can reject the null hypothesis of no effect of this
marker to the disease and that means some associations could exist between this marker and the
disease.
We can conclude, this time, that there are 52 significant markers for this test that represent a
3.32% of the total. Notice that in this case the most significant marker is also the 1190.
We find in this case 3.32% of significant markers which is below 5% so apparently data marker
information is not related to the disease.
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Again, we observe clustering in Figure 3.3. Moreover, if we compare Figures 3.3 and 3.1 we see
clustering in the same regions.
We are going to perform again the runs test in order to discard randomness of the sequence of
significant and non-significant results given by the exact test.
statistic p-value
-11.2879 2.2e-16
Table 3.11: Results of the runs test for randomness
Table 3.11 gives us the statistic and the p-value of the runs test for the sequence of significant and
non-significant results for the exact test.
As p-value (= 2.2e-16) < 0.05, we can reject the null hypothesis of randomness of the sequence.
In addition, it is interesting to realize that there are 47 markers that are significant for both tests.
These markers are the following:
7 8 12 220 242 245 429 441 480 481 605 688 698 752 753
754 755 756 761 762 763 772 773 774 958 976 1086 1161 1169 1177
1182 1187 1189 1190 1191 1192 1294 1298 1404 1405 1406 1408 1410 1425 1506
1507 1544
3.3. Tests for all the markers 31
3.3.3 Allele test for all the SNPs
Using the function we created to perform the allele test for one SNP, we calculate the p-value for
all the markers of the database.
In order to emphasize the significant markers, we apply -log() function to the p-value as we did in
previous subsections and we show the results in the following plot.
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Figure 3.4: Plot of -log(p-value) of the allele test for each SNP of the database
Figure 3.4 shows the plot of -log(p-value) for the allele test for each of the 1566 SNPs. Further,
the plot contains a horizontal line that allows us to see whether a marker is significant for this test
or not.
We have 49 significant markers for the allele test that represent a 3.12% of the total. Notice that
the most significant marker is again the 1190.
Let’s test for randomness of the sequence of significant and non-significant results given by the
allele test.
statistic p-value
-7.9318 2.16e-15
Table 3.12: Results of the runs test for randomness
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Table 3.12 gives us the statistic and the p-value of the runs test for the sequence of significant and
non-significant results for the allele test.
As p-value (= 2.16e-15) < 0.05, we can reject the null hypothesis of randomness of the sequence.
From the 47 markers that we already separated because of being significant for the previous tests,
only 19 are also significant for the allele test. These markers are the following:
242 245 605 761 1161 1169 1177 1182 1187 1189 1190 1191 1192 1404 1405
1406 1408 1410 1425
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3.3.4 Cochran-Armitage trend test for all the SNPs
Using the function we already create to perform the trend test for one SNP, we calculate the
statistic of the trend test for each SNP of the database.
The next figure contains the statistic value for all the SNPs and also two red lines that mark the
two critical values (N(0, 1)(0.05)) and (N(0, 1)(0.95)) because we are considering a two-sided test.
0 500 1000 1500
−
3
−
2
−
1
0
1
2
3
SNP
Z 
st
at
is
tic
Figure 3.5: Plot of the Z statistic of the Cochran-Armitage trend test for each SNP of the database
Figure 3.5 shows the statistic value for each SNP.
Performing this test we find 91 significant markers which is a number much larger than the ones
found for the other tests. The significant markers represent a 5.81% of the total which is more
than what we would expect due to chance.
We are going to test for randomness of the sequence of significant and non-significant results of
the trend test.
statistic p-value
1.8888 0.05892
Table 3.13: Results of the runs test for randomness
As Table 3.13 shows, the p-value (=0.059) > 0.05. In this case we can not reject the null hypothesis
of randomness of the sequence of results.
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How many markers are significant for all the tests?
Only 19 markers are significant in all the tests. These markers are the same ones that were
significant in the codominant test, the exact test and the allele test.
These 19 markers are the following:
242 245 605 761 1161 1169 1177 1182 1187 1189 1190 1191 1192 1404 1405
1406 1408 1410 1425
3.4 Results
In this section we characterize the markers that are significant in all tests in terms of their position,
minor allele frequency, HWE status and degree of significance in the codominant test. Results are
shown in Table 3.14.
Marker MAF p-value HWE p-value codominant test
242 0.34 0.53 0.02
245 0.35 0.07 0.01
605 0.47 0.18 0.04
761 0.42 0.50 0.05
1161 0.13 0.57 0.02
1169 0.11 0.02 0.01
1177 0.17 0.84 0.04
1182 0.47 0.11 0.01
1187 0.18 0.82 0.03
1189 0.28 0.29 0.03
1190 0.33 0.27 0.00
1191 0.25 0.40 0.00
1192 0.26 0.92 0.01
1404 0.06 0.84 0.04
1405 0.08 0.66 0.05
1406 0.06 0.76 0.01
1408 0.08 0.00 0.01
1410 0.07 0.76 0.02
1425 0.13 0.79 0.02
Table 3.14: Position, MAF, HWE status and degree of significance for the codominant test for the 19
markers that are significant in all the tests
Table 3.14 shows that the markers that are associated to colon cancer tend to occur in blocks
of more or less consecutive markers. At least two blocks of colon cancer related markers can be
distinguished. These are the markers with position 1161 through 1192 and 1404 through 1410.
The first block contains 9 markers and the second one 4 markers. 4 markers in the first block and
three markers in the second block are consecutive. The second block consists of markers with a
low MAF, in the range of 0.06-0.08.
Further, we construct a table that contains the counts at each combination of significant and non-
significant markers in the different tests. We do this in order to find out whether the tests are
consistent between each other. E.g. there are 1512 markers that are not significant in both allele
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test and codominant test, 5 markers that are significant in allele test but not in codominant test,
2 markers that are not significant in allele test but in codominant test and finally, 47 markers that
are significant in both tests.
Counts
Codominant test Exact test Allele test Cochran Armitage
Not Sig Sig Not Sig Sig Not Sig Sig Not Sig Sig
Codominant test
Not Sig 1517 0 1512 5 1490 27 1449 68
Sig 0 49 2 47 27 22 26 23
Exact test
Not Sig 3 1512 2 1514 0 1491 23 1451 63
Sig 5 47 0 52 26 26 24 28
Allele test
Not Sig 1490 27 1491 26 1517 0 1474 43
Sig 27 22 23 26 0 49 1 48
Cochran-Armitage
Not Sig 1449 26 1451 24 1474 1 1475 0
Sig 68 23 63 28 43 48 0 91
Table 3.15: Contingency table of the counts at each combination of significant and non-significant
markers in the different tests
Table 3.15 shows that exact and codominant tests are very similar. That means they reach to the
same conclusion for almost all the markers. Moreover, allele test and trend test also seem to be
similar but they differ more with the other two tests.
In addition, we show in the next table the results of the runs test for the sequencies of significant
and non-significant results of each test.
statistic p-value
Sequence of results codominant test -12.121 2.2e-16
Sequence of results exact test -11.2879 2.2e-16
Sequence of results allele test -7.9328 2.16e-15
Sequence of results Cochran-Armitage test 1.8888 0.05892
Table 3.16: Results of the runs test
We can see in Table 3.16 that the sequence of significant and non-significant markers of the
codominant test, the fisher test and the allele test are not considered random. The randomness
test for the the Cochran-Armitage test is not significant, but it’s p-value is so close to the 5%
threshold that some evidence against a random distribution of significant markers is present.
36 Chapter 3. Genetic Association Analysis
4
Simulations
In the previous chapter we found two distinguished clusters in the results of the tests. The first
cluster consists of markers with position 1161 through 1192 and the second one consists of mark-
ers with position 1404 through 1410. These markers are significant in all tests and furthermore,
we found that the results of the codominant test, the exact test and the allele test were not random.
In this chapter we are going to repeat some of the tests with simulated data marker. The objective
of this chapter is to deffend the idea that the clusters of significant markers found in all the tests
for the real marker data that we are studying are not random, but related in some way to the colon
cancer disease.
How do we simulate data marker?
For each of the 1566 SNPs, we calculate their genotype frequencies which gives us the proportion
of the three genotypes in our population (146 individuals). Once we have this probabilities, we
construct, for each SNP, a sample of size 146 where the elements(genotypes) will appear with the
given probabilities. As we do this for all the SNPs, what we get is a new database of 1566 markers
and their genotypes for the 146 individuals. The simulated database matches the original database
in the sense that the markers have the same genotype and allele frequencies, but are unrelated to
the disease indicator.
4.1 Codominant test for the simulated data
In this section we are going to repeat the codominant test using the simulated data we have created.
We give graphically -log(pvalue ) in order to emphasize the significant markers. The following
figure shows the significant markers that we get whith the genotypes for each SNP given randomly
for all the individuals.
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Figure 4.1: Plot of -log(p-value) of the chi-square test for each SNP of the simulated database
After doing the Codominant test for the simulated data marker, we can conclude that there are
80 significant markers that represent a 5.1% of the total. We find more significant markers in the
simulated data than in our database. In fact, the percentage of significant markers is very close to
what we would expect by chance (5%).
We do not see clustering in Figure 4.1 so the clustering we found seems to be characteristic of our
marker data.
Although it doesn’t seem to present clustering, we are going to perform the runs test and see what
it says about the randomnes of the sequence of significant and non-significant markers.
statistic p-value
0.0454 0.9638
Table 4.1: Results of the runs test for randomness
As we see in the table, the p-value (=0.96) > 0.05 so we can not reject de null hypothesis of
randomness of the sequence.
As a conclusion we say that if we generate random genotypes with same genotype frequencies that
we have in our data marker, we do not see clustering in the results and furthermore, the sequence
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of significant and non-significant markers is considered random.
4.2 Cochran-Armitage test for the simulated data
In this section we will perform the allele test for each SNP using the simulated data.
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Figure 4.2: Plot of -log(p-value) of the Cochran-Armitage test for each SNP of the simulated database
After doing the Cochran-Armitage test for the simulated data marker, we can conclude that there
are 148 significant markers that represent a 9.45% of the total. We find more significant markers
in the simulated data than in our database. In fact, we find more markers than we would expect
by chance.
We do not see clustering in Figure 4.2 so the clustering we found was characteristic of our data
marker.
Although it doesn’t seem to present clustering, we are going to perform the runs test and see what
it says about the randomnes of the sequence of significant and non-significant markers.
statistic p-value
1.1792 0.2383
Table 4.2: Results of the runs test for randomness
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As we see in the table, the p-value (=0.2383) > 0.05 so we can not reject de null hypothesis of
randomness of the sequence.
The two test we have performed with the simulated data marker do not present clustering in the
two regions we previously identified. Instead, we can say that the sequence of significant and
non-significant markers is random in this case.
5
Conclusions and
discussion
In this project we have analized a database containing marker information of 146 individuals, 47
of them suffering from colon cancer. The goal of this project was determine possible associations
between markers and the disease trait.
We initially had in our database the genotypes of these individuals for 1685 markers (SNPs). We
decided to remove 119 markers from the database either because they presented too much missings
or because they were monomorphic markers.
We first calculated the minor allele frequency (MAF) for each of the 1566 markers that remained in
our database after the removal. Calulating the MAF helped us to see the degree of variance these
markers presented. We found that markers with MAF in the range of 0.00 - 0.01 were relatively
more common, so a lot of markers were not very informative.
We also checked for Hardy Weinberg Equilibrium in order to discard genotyping error. Using the
HWTernaryP lot function we only found 138 significant markers which represent a 8.81% of the
total. Further, we tried to investigate if there were more significant markers in cases population
than in controls population. We did this because some investigators think that Hardy Weinberg
Equilibrium is more likely to hold in cases than in controls. We actually didn’t find evidences
of more disequilibrium in cases than in controls but that is probably because the sample size of
controls doubles the sample sizes of cases.
After doing an exhaustive description of our dataset, we started to test for associations between
the markers and the disease using four different models: The codominant test, the exact test, the
allele test and the Cochran-Armitage test.
These four tests do not yield identical results. We found strong agreement between the test results
of the codominant test and the exact test, and also between the alleles test and the CA test. We
found relatively more discrepancies between these two sets (see 3.15).
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The results of this tests are shown in the following table.
Test # significant markers %significant p-value runs test
Codominant test 49 3.12% 2.2e-16
Exact test 52 3.32% 2.2e-16
Allele test 49 3.12% 2.16e-15
Cochran-Armitage test 91 5.81% 0.059
Table 5.1: Results for each of the tests
As we can see in Table 5.1, the percentage of significant markers is somewhat lower than the
percentage expected by chance alone (5%). Only the Cochran-Armitage test gave a slightly higher
percentage of significant markers.
Although we haven’t found more significant markers than expected due to chance we have found
clustering in significant markers in the results of all the tests. Furthermore, the clustering has been
found in the same regions.
We have performed a test of randomnes to see if the sequences of significant and non-significant
markers can be considered random or not. We can see the results of this test in Table 5.1. For
three of the tests the sequence is not considered random so it is a signal that the clustering does
possibly exist. The randomness test for the the Cochran-Armitage test is not significant, but it’s
p-value is so close to the 5% threshold that some evidence against a random distribution of signif-
icant markers is present.
We also have determined which markers are significant for all the tests. We have found 19 markers.
These markers are the following:
242 245 605 761 1161 1169 1177 1182 1187 1189 1190 1191 1192 1404 1405
1406 1408 1410 1425
Two distinguished blocks of colon cancer related markers can be determined in this sequence of
19 markers. These are the markers with position 1161 through 1192 and 1404 through 1410. The
second block can be considered less informative because it contains markers with a low MAF (in
the range of 0.06 - 0.08).
Finally, by simulating new data marker we have seen that the two groups of significant markers
that have been found are not found when the data marker is randomly determined. Furthermore,
the sequences of significant and non-significant markers found after performing the codominant test
and the Cochran-Armitage test in this case can be considered random. Thus, we conclude that
some associations apparently exist between these two groups of markers and colon cancer disease.
Because we have done many statistical tests, we cannot exclude that the detected clusters represent
a chance effect. It would be interesting to see if our list of 19 significant markers again turns up
significant for new sample of cases and controls.
The observed clustering between significant markers may be due to correlation between neighbour-
ing markers (linkage disequilibrium). This could be studied in future work.
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